Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atrial fibrillation.

R W Sloan

    American Family Physician
    |June 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Atrial fibrillation can occur without clear heart disease. Digoxin helps control heart rate, and cardioversion is an option for selected patients with this common arrhythmia.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Aminoglycosides: once-daily dosing regimen.

    American family physician·1996
    Same author

    Principles of drug therapy in geriatric patients.

    American family physician·1992
    Same author

    Alternative first-line therapies in geriatric hypertension.

    Geriatrics·1989
    Same author

    Atrial fibrillation.

    The Journal of family practice·1986
    Same author

    Digitalis glycosides.

    American family physician·1983
    Same author

    Type I Hyperlipidemia.

    American family physician·1983

    Area of Science:

    • Cardiology
    • Electrophysiology

    Background:

    • Sustained atrial fibrillation (AF) often links to mitral valve disease, hypertension, cardiac failure, and atherosclerosis.
    • Idiopathic AF occurs without identifiable organic heart disease.

    Purpose of the Study:

    • To summarize the consequences of atrial fibrillation.
    • To outline management strategies for atrial fibrillation.

    Main Methods:

    • Literature review of atrial fibrillation pathophysiology and treatment.

    Main Results:

    • Atrial fibrillation can reduce cardiac output and lead to systemic emboli.
    • An exaggerated ventricular response during exercise is a consequence of AF.

    Conclusions:

    • Digoxin is typically the preferred medication for controlling the ventricular rate in AF.
    • Cardioversion is a viable treatment option for appropriately selected patients.